Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma

Chunbin Zhu(Shanghai Medical College of Fudan University), Diyang Xie(Fudan University), Jiaqiang Ma(Ministry of Education), Qiang Gao(Northeastern University), Bohao Zheng(Fudan University), Shu Zhang(Tianjin University of Technology), Xiaoming Zhang(Artistic Realization Technologies), Kai Zhu(Taishan Medical University), Liangqing Dong(Fudan University), Lei Yu(Fudan University), Dongning Rao(Fudan University)
JHEP Reports
April 15, 2023
10.1016/j.jhepr.2023.100762
Cited by 18

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
|Cancer Cell|2021|408
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
|Cell|2024|400
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387